Search

Your search keyword '"Zheng, Fred"' showing total 13 results
Start Over Author "Zheng, Fred" Journal blood
13 results on '"Zheng, Fred"'

2. Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Primary Analysis from a Phase 2 Study (CITADEL-204)

Author

Phillips, Tycel, primary, Avigdor, Abraham, additional, Gurion, Ronit, additional, Patti, Caterina, additional, Corradini, Paolo, additional, Tani, Monica, additional, Mehta, Amitkumar, additional, Lossos, Izidore S., additional, Zinzani, Pier Luigi Luigi, additional, Thieblemont, Catherine, additional, Jurczak, Wojciech, additional, Zheng, Fred, additional, Rappold, Erica, additional, Zhao, Wanying, additional, and Johnson, Peter, additional

Published
2021
Full Text
View/download PDF

3. Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Not Previously Treated with a BTK Inhibitor: Primary Analysis from a Phase 2 Study (CITADEL-205)

Author

Mehta, Amitkumar, primary, Trněný, Marek, additional, Walewski, Jan, additional, Ribrag, Vincent, additional, Dartigeas, Caroline, additional, Christensen, Jacob Haaber, additional, Pane, Fabrizio, additional, Rodriguez, Guillermo, additional, Taszner, Michal, additional, Venugopal, Parameswaran, additional, Zilioli, Vittorio Ruggero, additional, Zheng, Fred, additional, DeMarini, Douglas J, additional, Jiang, Wei, additional, and Zinzani, Pier Luigi Luigi, additional

Published
2021
Full Text
View/download PDF

4. Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Follicular Lymphoma: Primary Analysis from a Phase 2 Study (CITADEL-203)

Author

Lynch, Ryan C., primary, Avigdor, Abraham, additional, McKinney, Matthew S, additional, Paneesha, Shankara, additional, Wahlin, Björn, additional, Hrom, John S, additional, Cunningham, David, additional, Morley, Nicholas, additional, Canales, Miguel, additional, Bastos-Oreiro, Mariana, additional, Belada, David, additional, Devizzi, Liliana, additional, Zheng, Fred, additional, DeMarini, Douglas J, additional, Jiang, Wei, additional, and Trněný, Marek, additional

Published
2021
Full Text
View/download PDF

5. Bromodomain and Extra-Terminal Inhibitor INCB057643 (LIMBER-103) in Patients with Relapsed or Refractory Myelofibrosis and Other Advanced Myeloid Neoplasms: A Phase 1 Study

Author

Watts, Justin M., Vannucchi, Alessandro M., Hunter, Anthony M., McMahon, Brandon, Tantravahi, Srinivas K., Iurlo, Alessandra, Xicoy, Blanca, Palandri, Francesca, Searle, Emma, Reeves, Brandi N., Bose, Prithviraj, Ayala, Rosa, Halpern, Anna B., Chen, Xuejun, Burke, Lea M, Zhou, Feng, Zheng, Fred, and Vachhani, Pankit

Published
2023
Full Text
View/download PDF

6. Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Not Previously Treated with a BTK Inhibitor (CITADEL-205)

Author

Mehta, Amitkumar, primary, Trněný, Marek, additional, Walewski, Jan, additional, Ribrag, Vincent, additional, Dartigeas, Caroline, additional, Christensen, Jacob Haaber, additional, Pane, Fabrizio, additional, Rodríguez, Guillermo, additional, Taszner, Michal, additional, Venugopal, Parameswaran, additional, Zilioli, Vittorio Ruggero, additional, Zheng, Fred, additional, DeMarini, Douglas J, additional, Jiang, Wei, additional, and Zinzani, Pier Luigi, additional

Published
2020
Full Text
View/download PDF

7. Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

Author

Phillips, Tycel J., primary, Corradini, Paolo, additional, Gurion, Ronit, additional, Patti, Caterina, additional, Tani, Monica, additional, Avigdor, Abraham, additional, Jurczak, Wojciech, additional, Mehta, Amitkumar, additional, Zinzani, Pier Luigi, additional, Lossos, Izidore S., additional, Thieblemont, Catherine, additional, Zheng, Fred, additional, Rappold, Erica, additional, Zhao, Wanying, additional, and Johnson, Peter, additional

Published
2020
Full Text
View/download PDF

8. Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Follicular Lymphoma (CITADEL-203)

Author

Lynch, Ryan C., primary, Paneesha, Shankara, additional, Avigdor, Abraham, additional, McKinney, Matthew S, additional, Wahlin, Björn E, additional, Hrom, John S, additional, Belada, David, additional, Canales, Miguel, additional, Cunningham, David, additional, Devizzi, Liliana, additional, Morley, Nicholas, additional, Zheng, Fred, additional, DeMarini, Douglas J, additional, Jiang, Wei, additional, and Trněný, Marek, additional

Published
2020
Full Text
View/download PDF

9. Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Mantle Cell Lymphoma Previously Treated with Ibrutinib (CITADEL-205)

Author

Zinzani, Pier Luigi, primary, Delwail, Vincent, additional, Paneesha, Shankara, additional, Rule, Simon, additional, Martin Garcia-Sancho, Alejandro, additional, Marin-Niebla, Ana, additional, Salles, Gilles, additional, Sancho, Juan-Manuel, additional, Vergote, Vibeke, additional, Zilioli, Vittorio Ruggero, additional, Zheng, Fred, additional, DeMarini, Douglas J, additional, Jiang, Wei, additional, and Mehta, Amitkumar, additional

Published
2020
Full Text
View/download PDF

13. A Phase II Trial to Evaluate the Efficacy of Fostamatinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Author

Flinn, Ian, primary, Bartlett, Nancy L., additional, Blum, Kristie A., additional, Ardeshna, Kirit M, additional, LaCasce, Ann, additional, Flowers, Christopher R., additional, Shustov, Andrei R., additional, Thress, Kenneth, additional, Zheng, Fred, additional, Skolnik, Jeffery, additional, and Friedberg, Jonathan W., additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results